ANIMAL HEALTH NEWS-August

Veterinary conference in Argentina, FDA new approvals and Pet food recall, France using BI vaccines against influenza, company results, Biogenesis Bago new operations in Mexico, Zoetis and Elanco′s results, new management in MSD and Chanelle Pharma, new launches, distributor′s new projects and other news.

#animalhealth #veterinary #latinamerica #veterinaryindustry #news #newproducts #launched #newmanagers #events #distributors #pharmaceuticals #expansion #consultancyservices #softlanding #sales #marketing #fda #results #partnership #vaccines #nexusanimalhealth

?? The veterinary industry at the 31st Argentine Veterinary Conference: With a significant turnout of veterinarians, a new edition took place, and companies in the sector showcased their latest developments. On August 6th and 7th, the event was held at the Golden Center in Parque Norte, Buenos Aires, where the veterinary industry unveiled its innovations. Biogénesis Bagó continued to promote its awareness campaign #vaccinatewithlove, launched BIOchip, and officially announced the acquisition of Mayors Laboratory. Among the animal nutrition companies, the Royal Canin booth stood out as the Major Sponsor of the event. Other prominent companies had notable stands, including Zoetis , MSD , 勃林格殷格翰 , Fatro Von Franken , Brouwer S.A. , CEVA SANTE ANIMALE / Zoovet Productos Veterinarios , Over, John Martin, Purina Pro Plan, Sieger Tech , Elanco , Tecnovax, Producción Osspret , Per-Ros (Health and Accessories), JANVIER LABS , Afford, LABYES , Laboratorio Ruminal , Richmond, Baires, and Laboratorio Dermovet . (vetmarketportal.com.ar, 9th of August).

?? AUSTRALIA??National Veterinary Associates?announced it is selling Australian veterinary consolidator?VetPartners. Jefferies is taking the lead in marketing the company. VetPartners currently operates 267 clinics across Australia, New Zealand, and Singapore, and reported?revenues of $661 million in the most recent fiscal year.?(Energyportal.eu)

?? The FDA is cautioning pet owners that have purchased Darwin’s Natural Pet Products raw cat and dog food to not feed the food to their pets if they are under a certain lot number. The food, made by Arrow Reliance Inc, tested positive for?Salmonella?after the FDA tested samples. The following lots have received positive results1: (Lot 9774, manufactured on Jun 13, 2023- Lot 9795 manufactured on Jun 28, 2023-Lot 9830, manufactured on Jul 19, 2023). (dvm360.com, Aug. 17th).

?? FDA have approved afoxolaner, moxidectin, and pyrantel chewable tablets (NexGard?PLUS; 勃林格殷格翰 ) for canine protection from fleas, ticks, heartworm disease, roundworms, and hookworms. These monthly soft chews combine internal and external parasite protection with beef flavoring to help promote adherence, according to Boehringer Ingelheim. According to BI, clinical studies have demonstrated that afoxolaner, moxidectin, and pyrantel chewable tablets are safe and effective for dogs, against these parasitic threats. To help enable compliance, veterinarians can prescribe 3-dose and 6-dose presentations to best support the needs of their canine patients. (dvm360.com, Jul).

?? EU??Mars Incorporated?announced that it has entered into an agreement to acquire the assets of?SYNLAB Vet, a European provider of specialist veterinary laboratory diagnostics, from SYNLAB Group. Upon transaction close, SYNLAB Vet will join Mars Petcare. Financial terms were not disclosed.?(Businesswire).

?? France will receive up to 80 million doses from 勃林格殷格翰 for its avian influenza vaccination campaign planned for October. France has chosen Boehringer Ingelheim to vaccinate ducks in the autumn. The highly anticipated vaccination campaign for farmers is set to begin in October, according to the Ministry of Agriculture, for a period of six months. Each duck will receive two doses. The avian influenza virus epidemic, which has been prevalent in America, Europe, and Asia, has led to the euthanasia of tens of millions of poultry in France in recent years. (lefigaro.fr, July).

?? Revival Animal Health?announced the purchase of?Breeder’s Choice, a leading distributor of equine reproductive supplies. Financial terms were not disclosed.?(company press release).

?? Vimian Group ’s Interim Report for the second quarter of 2023: Last twelve months pro-forma revenues (including the full year impact of all acquisitions completed during the twelve months ending 30 June) reached EUR 329 million and pro-forma adjusted EBITA EUR 85.7 million. This means another quarter with strong growth and profitability, a positive momentum across their segments translated into 14% organic growth in the quarter. (vimian.com, Aug. 17th).

?? 勃林格殷格翰 :?announced that the FDA has approved Senvelgo (velagliflozin oral solution), for treating cats with diabetes. Senvelgo is a once-daily liquid oral solution that cat owners can give with a small amount of food or directly into the cat’s mouth. The drug can be admistered by pet parents in their cat’s food or directly in the cat’s mouth. Senvelgo will be available in veterinary clinics in the U.S. by mid-October.?(company press release).

?? Biogénesis Bagó , the international biotechnology company committed to its expansion in Mexico: The company has had its own subsidiary in Mexico since 2008, and with the appointment of Cristian Quinteros as Country Manager in 2020, it embarked on a new phase of expansion in the country, in line with the company's global objective of positioning itself among the top 20 animal health companies by 2026. Biogénesis Bagó Mexico's strategic focus revolves around three main areas: reproduction, injectable micromineral nutrition, and endectocides. (ganaderia.com, Aug 15th).

?? A challenging first half for Elanco , although the projections for the second half of 2023 are positive, as detailed in the results report published on Monday, August 7th. According to the document, from January to June, the multi headquartered in Greenfield, Indiana, United States, saw a decline in its revenues of -4%. During this period, it generated a total revenue of $2.314 billion. The Pets division experienced the most significant drop, with a -5% decrease, totaling $1.193 billion in the first half. Meanwhile, the Farm Animals division recorded a -2% decline, amounting to $1.100 billion. Breaking down this portfolio, their Cattle Livestock line experienced a -7% decline. The Aquaculture segment continues to perform positively during this period, as it did in 2022, with a 6% increase. In contrast, the Poultry portfolio grew by 2%, and the Swine portfolio increased by 1%. View presentation. (pharmabiz.net, Aug. 7th).

?? Zoetis Announces Second Quarter 2023 Results: The company reported revenue of $2.2 billion for the second quarter of 2023, an increase of 6% compared with the second quarter of 2022. On an operational1 basis, revenue for the second quarter of 2023 increased 9% compared with the second quarter of 2022, excluding the impact of foreign currency. Net income for the second quarter of 2023 was $671 million, or $1.45 per diluted share, an increase of 27% and 29%, respectively, on a reported basis. (Company press release, August).

?? MSD Animal Health Appoints New CEO: Last May, Brazilian executive Tiago Arantes left his position as the head of MSD Animal Health for Argentina and Chile. He moved up the organizational ladder to take on a global role within the company as Associate VP for Animal Production. In his place, the American company appointed fellow countryman Fabiano Hideto Ikejiri , who assumed his role remotely in July and has now arrived in the country to take the reins in person. Ikejiri, who joined MSD just over three years ago, previously served as the Operations & Strategy Director for Latin America from the company's office in S?o Paulo. (pharmabiz.net, Aug. 14th).

?? Phibro Animal Health Launches Autogenous Vaccine Line at the Southern Brazil Swine Symposium: Phibro unveiled PhiShield, its autogenous vaccine line, at the Southern Brazil Swine Symposium held in Chapecó, Santa Catarina. This type of vaccine is customized according to the specific issues affecting the herd and concerning the producer on their farm. Autogenous vaccines are personalized and utilize antigens derived from the farm's own population to stimulate a specific immune response against a particular disease. In practice, pathogens isolated from an affected animal on a farm are used to formulate vaccines that will be administered to the entire herd. This approach ensures greater homology since the targeted pathogen will be the same one spreading within the location. (jornaltribuna.com.br, Aug. 16th).

?? CEVA SANTE ANIMALE Animal Health Pays Tribute to Companies Recognizing Cevac IBras as a Key Ally for Animal Welfare: The vaccine has been awarded the "Animal Welfare-Friendly Company" seal, and now the French multinational extends its recognition to partner farms that use the tool to promote the five fundamental principles of animal welfare. Launched in 2016, Cevac IBras has become a milestone in the history of Brazilian poultry farming as it represents the only solution to the challenge faced by the national poultry industry against the most prevalent virus variant across the country, which causes Infectious Bronchitis, the second most economically impactful infectious disease worldwide in the sector. (jornaldiadia.com, Aug. 18th).

?? Eco Animal Health Group diversifying its product portfolio: Eco Animal Health plans to diversify into preventative disease solutions, such as vaccines and monoclonal antibodies, targeting the US market by the end of next year. The company is growing in China and other markets mostly focused in business, which specialises in developing, registering and marketing pharmaceutical products for global animal health markets and particularly for pigs and chickens. (finance.yahoo.com, July).

?? Vetalia , a Mexican startup founded by María Gutiérrez and Marion Benítez Landa in 2021, is on a mission to transform the pet care experience in Latin America. With most Mexican households having pets, Vetalia aims to improve the client’s experience and the quality of life for both pets and professionals in the animal care industry. The company provides a comprehensive solution through modern clinics and a technological platform. The platform serves as a “one-stop-shop” for all aspects of pet care, allowing customers to schedule appointments, access their pets’ medical history, and communicate with their veterinarian easily, by integrating technology into the pet care industry, and their vision includes integrating additional products and services, such as pet insurance and retail, to enhance the customer experience further. (claytoncountyregister.com, Aug. 12th).

?? Irish veterinary pharmaceutical company, Chanelle Pharma has appointed Abigail Donald (nee Busk) as the new head of UK for its animal health division. Donald will be responsible for leading sales, marketing, and product development of Chanelle Pharma’s animal health business across the UK. Prior to joining Chanelle in 2019, Abi, who lives in Gloucestershire, UK, completed a Master of Business Administration (MBA) and held senior roles in other animal health companies, including Zoetis and Ceva. (agriland.co.uk, Aug 1rst).

NEXUS ANIMAL HEALTH Expands Operations: The specialized consultancy in the Animal Health industry is extending its activities to the Middle East, Angola, Mozambique, Equatorial Guinea, and South Africa. As part of its expansion strategy, the company is forming partnerships with entities in these countries to further its growth. (animalhealthnexus.com, Aug. 9th.).

勃林格殷格翰 Animal Health Grew by Almost 4% in the First Half of 2023. Boehringer's adjusted net sales increased by 9.7%, thanks in part to the strong performance of NexGard in Animal Health, reaching 12.2 billion euros due to high demand for medications during the first six months of 2023. This was driven by robust growth in Jardiance? in the Human Health sector and NexGard? in Animal Health. In terms of Animal Health, there was growth in both Companion Animals and Production Animals, with a 3.8% increase (adjusted for currency fluctuations), bringing the total sales to 2.5 billion euros in the first ?half of the year. (animalshealth.es, Aug 11).

?? The Argentine distributor of veterinary products, Esperanza Distribuciones , has launched a new online purchasing platform to boost its sales in the veterinary channel. Operating under the slogan "the smartest way to shop," Esperanza Distribuciones now offers various digital options for veterinary products (pharmaceuticals and biologicals) for different animal species. As part of a series of investments that included rebranding the company and introducing innovations in its facilities and working methods, one of Argentina's leading veterinary distributors is now advancing with a revamped digital image. (motivar.com.ar, Aug. 18th).

?? LIVISTO to Distribute the Complementary Food for Dogs and Cats, Artennua, in Spain: Biotech Tricopharming Research has entered into a collaboration agreement with Livisto for the exclusive distribution of its product Artennua? in Spain. Artennua? consists of 100% plant-based complementary food capsules, which will also be available in the market with a new formulation. The aim of this collaboration is to expand the Artennua? brand throughout Spain while preserving its identity within the co-branding project with Livisto Spain. Livisto is an international pharmaceutical company with extensive experience in the veterinary sector, specializing in the development, production, and marketing of high-quality products for animal health. Livisto operates in more than 100 countries, with its headquarters located in five European cities and two in Latin America. (animalshealth.es, Aug).

?? Drovet Inaugurates Its Distribution Center: The Argentine distributor based in Rosario, DROVET, has inaugurated its modern and advanced distribution center for veterinary products. This move is expected to bring greater operational efficiency for customers and business partners. The distribution center is strategically located in the Park Empresario in the city of Santa Fe, on a 7,000 square meter plot with quick access points. This facilitates the receipt of merchandise from distant locations while expediting the delivery of orders across the country. The facility encompasses 2,000 square meters of covered space and approximately 3,000 storage positions, effectively doubling the current storage capacity. (motivar.com.ar, Aug. 19th).

?? Brouwer S.A. Introduces Power Gold in Paraguay: The Argentine veterinary laboratory recently unveiled its product to over 250 veterinarians in Paraguay. The event featured a discussion on management and sales strategies and was jointly organized by the laboratory and its local distributor, Chimiray. The event took place at the Olympic Committee Hall in Asunción, Paraguay. (motivar.com.ar, Aug 10th).

Did you find this useful? Please, follow...?? NEXUS ANIMAL HEALTH or BERNARDO OTERO and subscribe to the newsletter.

Please, "repost" for others to read it.

?